GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (FRA:20B) » Definitions » FCF Yield %

Biomark Diagnostics (FRA:20B) FCF Yield % : -4.32 (As of May. 18, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Biomark Diagnostics's Trailing 12-Month Free Cash Flow is €-0.65 Mil, and Market Cap is €14.74 Mil. Therefore, Biomark Diagnostics's FCF Yield % for today is -4.32%.

The historical rank and industry rank for Biomark Diagnostics's FCF Yield % or its related term are showing as below:

FRA:20B' s FCF Yield % Range Over the Past 10 Years
Min: -6.62   Med: -3.31   Max: 1.86
Current: -4.32


During the past 10 years, the highest FCF Yield % of Biomark Diagnostics was 1.86%. The lowest was -6.62%. And the median was -3.31%.

FRA:20B's FCF Yield % is ranked worse than
52.59% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.465 vs FRA:20B: -4.32

Biomark Diagnostics's FCF Margin % for the quarter that ended in Dec. 2023 was -1,193.10%.


Biomark Diagnostics FCF Yield % Historical Data

The historical data trend for Biomark Diagnostics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics FCF Yield % Chart

Biomark Diagnostics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.43 -3.43 -2.60 -7.54 -5.97

Biomark Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.36 -4.54 -4.38 -0.21 -10.36

Competitive Comparison of Biomark Diagnostics's FCF Yield %

For the Diagnostics & Research subindustry, Biomark Diagnostics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomark Diagnostics's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's FCF Yield % falls into.



Biomark Diagnostics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Biomark Diagnostics's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.627 / 10.4940612
=-5.97%

Biomark Diagnostics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.346 * 4 / 13.3602714
=-10.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomark Diagnostics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Biomark Diagnostics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (FRA:20B) Business Description

Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (FRA:20B) Headlines

No Headlines